SeaStar Medical (NASDAQ:ICU) Announces Earnings Results

SeaStar Medical (NASDAQ:ICU) released its quarterly earnings results on Thursday. The company reported ($0.90) earnings per share for the quarter, missing the consensus estimate of ($0.89) by ($0.01), Zacks reports. The business had revenue of $0.07 million during the quarter, compared to the consensus estimate of $0.15 million.

SeaStar Medical Trading Down 9.5 %

SeaStar Medical stock opened at $2.20 on Friday. The stock has a market cap of $14.24 million, a PE ratio of -0.19 and a beta of -0.97. The stock has a 50-day moving average price of $1.87 and a 200 day moving average price of $2.65. SeaStar Medical has a 52 week low of $1.50 and a 52 week high of $20.70.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.